Impact of Heme During Group A Streptococcus Infection
A 族链球菌感染期间血红素的影响
基本信息
- 批准号:10825476
- 负责人:
- 金额:$ 64.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-02 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:Acute DiseaseAntibodiesAreaBindingBiochemicalCell WallComplementComplexCuesDevelopmentDimensionsDiseaseDrug Metabolic DetoxicationElementsFunctional disorderGene ExpressionGenesGoalsGroup ProcessesGrowthHemeHeme IronHemeproteinsHemostatic functionHomeostasisHumanHuman bodyHypersensitivityIndividualInfectionInflammationInjuryInterventionIronMediatorMembrane LipidsMembrane ProteinsMetabolismMetalsMethodsModalityMolecularMolecular GeneticsMonitorMuramidaseMutagenesisNatureNutrientNutritionalNutritional ImmunityOperonPathogenesisPathway interactionsPhosphotransferasesPlayPreventionPropertyProteinsReactive Oxygen SpeciesRegulatory PathwayResearch PersonnelResistanceRoleShapesSignal TransductionSourceStreptococcal InfectionsStreptococcus pyogenesStressSystemTestingToxic effectVirulenceVirulence Factorscell envelopecell injurydifferential expressionexperienceextracellularfitnessgenetic regulatory proteingenome-wideheme aheme receptorholistic approachhuman pathogenin vivoinsightlipophilicitynovelnovel strategiespathogenrepairedresponsesensorsuccesstranscriptometransposon sequencinguptakevaccine accessvirulence gene
项目摘要
Project Summary
The overarching goal of this collaborative project is to define the role of heme in the
pathophysiology of the Group A Streptococcus (GAS) with the aim of developing new treatment
modalities. In the human host, heme has two roles: both a critical nutrient and a noxious agent.
Thus, for the β-hemolytic GAS, heme management requires a delicate balancing act. We
hypothesize that GAS carefully monitors the levels of heme in both the extracellular and
intracellular compartments and accordingly deploys heme uptake and use or detoxification and
repair pathways. Furthermore, we propose that GAS uses heme-sensitive regulatory proteins to
influence the expression of both iron-homeostasis and virulence genes. In this application, two
experienced GAS researchers (MPIs Eichenbaum and McIver) will combine molecular genetic and
biochemical methods with transcriptome studies and genome-wide mutagenesis screens to
identify and characterize GAS mechanisms for heme management and establish their role in GAS
pathogenesis; We describe key heme uptake pathways and GAS pathophysiology (Aim 1);
characterize the mechanisms that facilitate heme resistance in the GAS envelope (Aim 2); and
analyze the regulatory framework that orchestrates GAS adaptation according to environmental
heme (Aim 3). This project will help reveal the fundamental impact of heme in the
pathophysiology of a major human pathogen.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZEHAVA EICHENBAUM其他文献
ZEHAVA EICHENBAUM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZEHAVA EICHENBAUM', 18)}}的其他基金
Examining SecA as a Potential Target for Treating Gram-positive Bacteria
检查 SecA 作为治疗革兰氏阳性菌的潜在靶点
- 批准号:
8913328 - 财政年份:2014
- 资助金额:
$ 64.72万 - 项目类别:
Iron Acquisition From Host Proteins in S. pyogenes
从化脓性链球菌宿主蛋白中获取铁
- 批准号:
7224930 - 财政年份:2004
- 资助金额:
$ 64.72万 - 项目类别:
Iron Acquisition From Host Proteins in S. pyogenes
从化脓性链球菌宿主蛋白中获取铁
- 批准号:
6835437 - 财政年份:2004
- 资助金额:
$ 64.72万 - 项目类别:
Iron Acquisition From Host Proteins in S. pyogenes
从化脓性链球菌宿主蛋白中获取铁
- 批准号:
7054137 - 财政年份:2004
- 资助金额:
$ 64.72万 - 项目类别:
Iron Acquisition From Host Proteins in S. pyogenes
从化脓性链球菌宿主蛋白中获取铁
- 批准号:
6891287 - 财政年份:2004
- 资助金额:
$ 64.72万 - 项目类别:
Iron Acquisition From Host Proteins in S. pyogenes
从化脓性链球菌宿主蛋白中获取铁
- 批准号:
7407996 - 财政年份:2004
- 资助金额:
$ 64.72万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 64.72万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 64.72万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 64.72万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 64.72万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 64.72万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 64.72万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 64.72万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 64.72万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 64.72万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 64.72万 - 项目类别: